WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today debuts its enhanced imaging portfolio designed to drive innovation across diverse applications in preclinical research with the launch ...

Revvity RVTY announced that it has launched three next-generation technologies that aim to help scientists drive breakthrough discoveries in biological research. These technologies include the IVIS ...

Historically, optical imaging in small animal models was primarily used to evaluate drug efficacy—to answer the question, is a tumor growing or regressing in response to therapy? “We have moved beyond ...

In its first full quarter as a life sciences and diagnostics company—after PerkinElmer’s non-medtech divisions were sold off to the private equity firm New Mountain Capital in mid-March—Revvity saw ...